|
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 122,08 CHF | +0,44% |
|
+3,48% | +11,39% |
| 12/06 | Novartis: Rhapsido raggiunge gli endpoint primari nello studio sull'orticaria cronica inducibile | MT |
| 12/06 | SMI, è l'ora del rimpasto? Galderma e Sandoz pronti all'ingresso | AW |
Principali concorrenti
Aggiungi a una lista 0 selezionato | Variaz. | Variaz. 5g. | Variazione 1 mese | Variazione 3 mesi | Variaz. 1 gen. | Variaz. 1 anno | Variaz. 3 anni | Variaz. 5 anni | Variaz. 10 anni | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,44% | +3,48% | +5,33% | +1,03% | +11,39% | +24,48% | +34,39% | +46,52% | +60,10% | 281 Mrd | |
| -2,41% | +0,14% | +14,46% | +15,94% | +5,43% | +39,53% | +154,43% | +405,60% | +1.432,12% | 1.010 Mrd | |
| +1,07% | +3,48% | +7,41% | -0,48% | +16,39% | +53,75% | +50,64% | +46,02% | +105,85% | 580 Mrd | |
| +1,32% | +0,22% | +9,56% | +1,05% | -0,33% | +18,35% | +65,35% | +97,31% | +273,33% | 402 Mrd | |
| +0,77% | 0,00% | +1,74% | +2,80% | -0,34% | +19,99% | +16,80% | -4,36% | +30,42% | 330 Mrd | |
| -1,42% | -1,44% | +5,94% | +2,71% | +13,10% | +45,50% | +8,37% | +56,09% | +109,56% | 294 Mrd | |
| -0,85% | -2,86% | -2,08% | -6,28% | -2,38% | +22,05% | +13,80% | +61,41% | +249,48% | 280 Mrd | |
| +1,66% | +1,20% | -3,12% | +16,30% | -11,68% | -44,67% | -47,49% | +11,16% | +57,61% | 197 Mrd | |
| +0,32% | +1,61% | +5,62% | -3,42% | +8,52% | +19,48% | +63,42% | +46,31% | +129,49% | 192 Mrd | |
| -0,22% | -2,76% | -6,93% | -13,51% | +2,32% | +12,08% | +61,30% | +82,62% | +48,72% | 156 Mrd | |
| +0,15% | +0,65% | +1,31% | -2,42% | +5,26% | +5,52% | -34,31% | -34,72% | -25,73% | 149 Mrd | |
| +0,40% | -0,24% | +1,20% | -3,09% | +5,91% | +12,70% | -11,78% | -15,16% | -21,36% | 117 Mrd | |
| -0,03% | -0,43% | -0,75% | -6,94% | -1,86% | -3,29% | +30,63% | +130,51% | +386,31% | 113 Mrd | |
| +0,38% | -1,74% | +4,40% | +0,09% | -7,41% | -12,65% | -19,40% | -13,85% | +8,73% | 106 Mrd | |
| +1,10% | +2,37% | +4,89% | -2,31% | +8,74% | +28,04% | +44,42% | +13,10% | +12,29% | 106 Mrd | |
| +0,30% | -1,38% | -4,41% | -20,99% | -9,62% | -1,31% | +84,00% | +70,17% | +485,85% | 76,54 Mrd | |
| +0,97% | +3,17% | -1,66% | -10,29% | +5,11% | +16,16% | +12,83% | +34,48% | +11,62% | 50,12 Mrd | |
| +3,21% | +2,99% | -13,58% | -12,31% | -18,60% | -13,13% | +8,48% | -33,54% | +235,95% | 47,41 Mrd | |
| +1,12% | +0,08% | -5,85% | -7,51% | -2,22% | +30,09% | -29,19% | -32,32% | -58,88% | 41,16 Mrd | |
| +0,20% | +1,29% | -3,30% | +18,19% | +10,96% | +95,54% | +373,73% | +211,70% | -34,67% | 40,32 Mrd | |
| Media | +0,19% | +0,77% | +1,01% | -1,57% | +1,93% | +18,41% | +44,02% | +58,95% | +174,84% | 228,51 Mrd | |
| Media ponderata per Capi. | -0,57% | +0,78% | +5,51% | +2,83% | +4,64% | +25,62% | +58,32% | +123,70% | +410,44% |
- Mercati
- Azioni
- Azione NOVN
- Settore Novartis AG
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale